| Lokaci | Farashin Hasashen | Baya | Na tarihi | Hankali |
|---|---|---|---|---|
| Gobe | $67.74 ▼ -0.97% | Jiya | $68.69 ▲ +0.41% | Saitin Halozyme Therapeutics Inc. Common Stock (HALO) na gobe yana angare zuwa $68.41 kuma yana hari $67.74 (-0.97%). Karatun da ke kusa shine kasa; kalli $70.46 / $66.36 saboda yau da kullun da aka gane sauyin yanayi shine kusan 5.01%. |
Saitin Halozyme Therapeutics Inc. Common Stock (HALO) na gobe yana angare zuwa $68.41 kuma yana hari $67.74 (-0.97%). Karatun da ke kusa shine kasa; kalli $70.46 / $66.36 saboda yau da kullun da aka gane sauyin yanayi shine kusan 5.01%. | ||||
| Mako | $66.34 ▼ -3.02% | Makon da ya gabata | $69.28 ▲ +1.27% | Samfurin 7-rana Halozyme Therapeutics Inc. Common Stock yana motsawa daga $69.28 zuwa $66.34 (-3.02%). Yana ba kasa mahallin yanayi mai ƙarfi don wannan hannun jari, don haka ya karya a kusa da $70.46 / $66.36 al'amarin fiye da kaska ɗaya. |
Samfurin 7-rana Halozyme Therapeutics Inc. Common Stock yana motsawa daga $69.28 zuwa $66.34 (-3.02%). Yana ba kasa mahallin yanayi mai ƙarfi don wannan hannun jari, don haka ya karya a kusa da $70.46 / $66.36 al'amarin fiye da kaska ɗaya. | ||||
| Watan | $64.00 ▼ -6.44% | A watan da ya gabata | $70.26 ▲ +2.71% | 1-wata Halozyme Therapeutics Inc. Common Stock manufa ita ce $64.00 (-6.44%), idan aka kwatanta da rayayyun bayanai kusa da $68.41. Wannan sararin sama yana haɗa matsin lamba na halin yanzu tare da ƙwaƙƙwaran farashi, yawan ruwa, da ƙayyadaddun haɗari na kamfani. |
1-wata Halozyme Therapeutics Inc. Common Stock manufa ita ce $64.00 (-6.44%), idan aka kwatanta da rayayyun bayanai kusa da $68.41. Wannan sararin sama yana haɗa matsin lamba na halin yanzu tare da ƙwaƙƙwaran farashi, yawan ruwa, da ƙayyadaddun haɗari na kamfani. | ||||
| Shekara | $60.50 ▼ -11.57% | Shekaran da ya gabata | $71.73 ▲ +4.86% | Yanayin 1-shekara Halozyme Therapeutics Inc. Common Stock yana nuna $60.50 (-11.57%). Amincewa ya yi ƙasa da layuka na ɗan gajeren lokaci, don haka ɗaukar shi azaman mahallin sake zagayowar kuma sake duba shi bayan manyan sabunta bayanan kasuwa. |
Yanayin 1-shekara Halozyme Therapeutics Inc. Common Stock yana nuna $60.50 (-11.57%). Amincewa ya yi ƙasa da layuka na ɗan gajeren lokaci, don haka ɗaukar shi azaman mahallin sake zagayowar kuma sake duba shi bayan manyan sabunta bayanan kasuwa. | ||||
| Shekaru 5 | $52.28 ▼ -23.57% | 5 Shekarun da suka gabata | $75.18 ▲ +9.90% | Duban 5-shekara Halozyme Therapeutics Inc. Common Stock shine $52.28 (-23.57%). Yanayi yanayin jagora ne wanda aka gina daga iyakataccen faifai da rashin ƙarfi, ba tabbataccen hanya ba. |
Duban 5-shekara Halozyme Therapeutics Inc. Common Stock shine $52.28 (-23.57%). Yanayi yanayin jagora ne wanda aka gina daga iyakataccen faifai da rashin ƙarfi, ba tabbataccen hanya ba. | ||||
| Mai nuna alama | Daraja | Sigina |
|---|---|---|
| Farashin | $68.41 | Tsakar |
| Canjin Kullum | -1.67% | A ƙasa |
| Ƙarfin Ƙarfafawa | 20.0% | Tsakar |
| Amincewa | 61% | A ƙasa |
| Tushen Bayanai | nasdaq-screener | Tsakar |
| A halin yanzu | $68.41 | Canjin Kullum | -1.67% |
| Darajar kasuwa | $8.10B | Source | nasdaq-screener |
Ra'ayoyi masu alaƙa don kewayawa a ciki, an tattara su bisa mafi ƙarfi na tashi da mafi rauni na sauka a cikin kasuwa guda.